BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, February 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 11, 2007
View Archived Issues
Novel series of anticancer compounds disclosed in recent patents
Read More
Recent Inotek patent reports new agents for treating urinary incontinence
Read More
Novel diagnostic agents imparted in recent patents
Read More
Cytyc completes acquisition of Adeza Biomedical
Read More
Genta files appeal against FDA decision on Genasense for CLL
Read More
Lilly completes acquisition of Hypnion
Read More
Survival benefit for lenalidomide plus low-dose dexamethasone in multiple myeloma
Read More
Immune Response changing name to Orchestra Therapeutics
Read More
MM-093 begins pilot study in autoimmune uveitis
Read More
Amgen updates Vectibix progress
Read More
IND clearance for phase II study of CollaRx Bupivacaine Implant in hysterectomy
Read More
Vekacia demonstrates efficacy in vernal keratoconjunctivitis phase III trial
Read More
Erbitux and platinum-based chemotherapy increases survival in SCCHN
Read More
PRT-054021 effective and safe for VTE prevention after knee replacement surgery
Read More
Tovaxin reduces annualized relapse rate in MS
Read More
Zentase meets endpoints in phase III exocrine pancreatic insufficiency trials
Read More
Positive findings for guanilib in animal models of experimental colitis
Read More
New Nav1.8 channel blockers with potential utility in chronic pain management
Read More
Ariad receives FDA feedback on pivotal study of AP-23573 for metastatic sarcoma
Read More
NP-1 begins two phase IIb trials for neuropathic pain
Read More
Phase II trial studies glufosfamide for soft tissue sarcoma
Read More
Alteon and Oxis expand licensing deal
Read More
Phase IIa Alzheimer's study of MEM-1003 completes enrollment
Read More
Phase II study of Curaxin CBLC-102 in prostate cancer advances to next stage
Read More
Novel PARP-1 inhibitor described by Abbott
Read More
NDA filing for local dental anesthetic reversal agent NV-101
Read More
HepaGam B approved to prevent hepatitis B recurrence in liver transplant patients
Read More
Intrinsa launched in U.K.
Read More
